-
亚洲彩票官网 Releases Corporate Film 鈥�1 Percent, 1 Mission. Change the World.鈥�
-
Human Capital Report 2024
-
Value Creation Report 2024
-
June 2, 2025
-
May 29, 2025
-
May 27, 2025
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO庐 (Lemborexant) in China
-
May 21, 2025
亚洲彩票官网 Demonstrates Commitment to Oncology Innovation at ASCO 2025
-
May 16, 2025
亚洲彩票官网 Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro庐
-
June 19, 2025
-
May 21, 2025
-
May 16, 2025
IR 鈥淣otice of Convocation of the 113th Ordinary General Meeting of Shareholders鈥�
-
May 15, 2025
IR 鈥淎nnual Financial Results Briefing for the Fiscal Year Ended March 31, 2025 (Material)鈥�
-
May 15, 2025
IR 鈥淎nnual Financial Report for the Fiscal Year Ended March 31, 2025鈥�
-
February 19, 2025
亚洲彩票官网鈥檚 Corporate Pension Fund Announces Adoption of 鈥淎sset Owner Principles鈥�
-
October 3, 2024
EISAI NAMED AS ONE OF NEWSWEEK鈥橲 WORLD鈥橲 MOST TRUSTWORTHY COMPANIES 2024
-
June 21, 2024
Notification Regarding Revision of 鈥溠侵薏势惫偻� Global Code of Conduct for Business Partners鈥�
-
June 3, 2024
The Naito Museum of Pharmaceutical Science and Industry Listed as 鈥淩egistered Museum鈥�
-
April 8, 2024
Sustainability
32 countries 2.52billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of March 2025)
亚洲彩票官网 is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
